TransMedics (TMDX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $70.78, -7.50% vs the prior close of $76.52.
- Volume 1.07M shares, 1.4x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TMDX slides 7.5% to $70.78, a 3-month low. Closed at $70.78, -7.50% vs the prior close of $76.52. Day range $70.03–$76.52, opened at $76.52.
TMDX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TMDX slides 7.5% to $70.78, a 3-month low
- Closed at $70.78, -7.50% vs the prior close of $76.52. Day range $70.03–$76.52, opened at $76.52.
- Volume was 1.07M shares, 1.4x its 50-day average of 754.96K.
- Price is -17.1% vs its 50-day average ($85.43) and -27.5% vs its 200-day average ($97.64).
- 52-week range $60.10–$156.00; today's close sits at 11% of that range, 54.6% below the 52-week high.
Oct 15, 2026 — TMDX rises 1.3% to $76.52
- Closed at $76.52, +1.32% vs the prior close of $75.52. Day range $74.41–$77.34, opened at $74.41.
- Volume was 1.13M shares, 1.4x its 50-day average of 791.40K.
- Price is -10.6% vs its 50-day average ($85.62) and -21.8% vs its 200-day average ($97.90).
- 52-week range $60.10–$156.00; today's close sits at 17% of that range, 50.9% below the 52-week high.
Oct 14, 2026 — TMDX slides 4.6% to $75.52, a 1-month low
- Closed at $75.52, -4.57% vs the prior close of $79.14. Day range $74.84–$78.36, opened at $78.20.
- Volume was 891.40K shares, 1.1x its 50-day average of 806.26K.
- Price is -11.8% vs its 50-day average ($85.62) and -23.0% vs its 200-day average ($98.13).
- 52-week range $60.10–$156.00; today's close sits at 16% of that range, 51.6% below the 52-week high.
Oct 13, 2026 — TMDX rises 1.2% to $79.14
- Closed at $79.14, +1.23% vs the prior close of $78.17. Day range $77.86–$80.42, opened at $78.17.
- Volume was 1.03M shares, 1.3x its 50-day average of 816.10K.
- Price is -7.7% vs its 50-day average ($85.72) and -19.6% vs its 200-day average ($98.38).
- 52-week range $60.10–$156.00; today's close sits at 20% of that range, 49.3% below the 52-week high.
Oct 12, 2026 — TMDX rises 0.4% to $78.17
- Closed at $78.17, +0.39% vs the prior close of $77.87. Day range $77.14–$78.50, opened at $77.69.
- Volume was 491.70K shares, 0.6x its 50-day average of 816.92K.
- Price is -8.9% vs its 50-day average ($85.77) and -20.7% vs its 200-day average ($98.62).
- 52-week range $60.10–$156.00; today's close sits at 19% of that range, 49.9% below the 52-week high.
Oct 9, 2026 — TMDX dips 1.4% to $77.87, a 1-month low
- Closed at $77.87, -1.43% vs the prior close of $79.00. Day range $76.86–$81.35, opened at $79.13.
- Volume was 733.70K shares, 0.9x its 50-day average of 819.94K.
- Price is -9.2% vs its 50-day average ($85.74) and -21.2% vs its 200-day average ($98.87).
- 52-week range $60.10–$156.00; today's close sits at 19% of that range, 50.1% below the 52-week high.
Oct 8, 2026 — TMDX dips 2.6% to $79.00
- Closed at $79.00, -2.55% vs the prior close of $81.07. Day range $77.50–$80.28, opened at $80.25.
- Volume was 949.40K shares, 1.2x its 50-day average of 825.49K.
- Price is -7.8% vs its 50-day average ($85.70) and -20.3% vs its 200-day average ($99.12).
- 52-week range $60.10–$156.00; today's close sits at 20% of that range, 49.4% below the 52-week high.
Oct 7, 2026 — TMDX rises 1.0% to $81.07
- Closed at $81.07, +0.98% vs the prior close of $80.28. Day range $80.56–$83.90, opened at $80.96.
- Volume was 962.60K shares, 1.2x its 50-day average of 821.61K.
- Price is -5.4% vs its 50-day average ($85.68) and -18.4% vs its 200-day average ($99.37).
- 52-week range $60.10–$156.00; today's close sits at 22% of that range, 48.0% below the 52-week high.
Oct 6, 2026 — TMDX slides 3.3% to $80.28
- Closed at $80.28, -3.27% vs the prior close of $82.99. Day range $80.08–$84.05, opened at $83.87.
- Volume was 570.70K shares, 0.7x its 50-day average of 823.07K.
- Price is -6.2% vs its 50-day average ($85.59) and -19.4% vs its 200-day average ($99.57).
- 52-week range $60.10–$156.00; today's close sits at 21% of that range, 48.5% below the 52-week high.
Oct 5, 2026 — TMDX jumps 4.0% to $82.99
- Closed at $82.99, +4.00% vs the prior close of $79.79. Day range $77.37–$83.40, opened at $79.50.
- Volume was 994.90K shares, 1.2x its 50-day average of 825.96K.
- Price is -2.9% vs its 50-day average ($85.47) and -16.8% vs its 200-day average ($99.77).
- 52-week range $60.10–$156.00; today's close sits at 24% of that range, 46.8% below the 52-week high.
Oct 2, 2026 — TMDX rises 1.5% to $79.79
- Closed at $79.79, +1.47% vs the prior close of $78.64. Day range $77.14–$80.85, opened at $79.81.
- Volume was 1.22M shares, 1.5x its 50-day average of 813.51K.
- Price is -6.4% vs its 50-day average ($85.25) and -20.2% vs its 200-day average ($99.98).
- 52-week range $60.10–$156.00; today's close sits at 21% of that range, 48.8% below the 52-week high.
TMDX latest news & SEC filings
Every SEC filing by or about TMDX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Weill David bought 1,336 shares at $81.63 (≈$109.06K) on Sep 11, 2026
- Weill David bought 1,336 shares at $81.63 (≈$109.06K) on Sep 11, 2026
- Weill David bought 1,336 shares at $81.63 (≈$109.06K) on Sep 11, 2026
- Weill David bought 1,336 shares at $81.63 (≈$109.06K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $189.95M (prior year $157.37M) (+20.7% vs Jun 30, 2025)
- Net income: $14.68M (prior year $34.91M) (-57.9% vs Jun 30, 2025)
- Diluted EPS: $0.41 (prior year $0.92) (-55.4% vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade TMDX
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 27, 2026, Feb 24, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.41% (largest 7.5%).
- Liquidity: about 781.54K shares (≈$55.32M) trade per day on average.
- 52-week position: $70.78 vs a range of $60.10–$156.00 (11% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: David Weill bought 1,336 shares on Sep 11, 2026.
- Latest filings: 8-K Sep 10, 2026; 10-Q Aug 4, 2026; 8-K Aug 4, 2026.
- Share count: 34.68M shares outstanding (Jul 30, 2026), +1.7% vs a year earlier.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
TMDX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 76.52 | 76.52 | 70.03 | 70.78 | 1.07M |
| Oct 15, 2026 | 74.41 | 77.34 | 74.41 | 76.52 | 1.13M |
| Oct 14, 2026 | 78.20 | 78.36 | 74.84 | 75.52 | 891.40K |
| Oct 13, 2026 | 78.17 | 80.42 | 77.86 | 79.14 | 1.03M |
| Oct 12, 2026 | 77.69 | 78.50 | 77.14 | 78.17 | 491.70K |
| Oct 9, 2026 | 79.13 | 81.35 | 76.86 | 77.87 | 733.70K |
| Oct 8, 2026 | 80.25 | 80.28 | 77.50 | 79.00 | 949.40K |
| Oct 7, 2026 | 80.96 | 83.90 | 80.56 | 81.07 | 962.60K |
| Oct 6, 2026 | 83.87 | 84.05 | 80.08 | 80.28 | 570.70K |
| Oct 5, 2026 | 79.50 | 83.40 | 77.37 | 82.99 | 994.90K |
| Oct 2, 2026 | 79.81 | 80.85 | 77.14 | 79.79 | 1.22M |
| Oct 1, 2026 | 83.92 | 84.24 | 78.02 | 78.64 | 880.10K |
| Sep 30, 2026 | 84.87 | 84.87 | 81.55 | 83.45 | 566.60K |
| Sep 29, 2026 | 82.56 | 84.22 | 81.75 | 84.07 | 440.20K |
| Sep 28, 2026 | 86.38 | 86.38 | 82.70 | 82.73 | 422.50K |
| Sep 25, 2026 | 83.50 | 85.69 | 81.80 | 85.29 | 696.70K |
| Sep 24, 2026 | 86.09 | 86.09 | 82.53 | 83.90 | 623.70K |
| Sep 23, 2026 | 88.22 | 89.19 | 85.07 | 87.00 | 615.60K |
| Sep 22, 2026 | 88.15 | 89.80 | 86.50 | 88.07 | 750.70K |
| Sep 21, 2026 | 87.35 | 89.53 | 86.75 | 87.29 | 590.80K |
About TransMedics
TransMedics (TMDX) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in ANDOVER, MA. State of incorporation: MA. Fiscal year ends December 31. SEC CIK 1756262.
TMDX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Edward M Basile | Director | May 22, 2026 |
| Thomas J. Gunderson | Director | Jun 17, 2026 |
| Waleed H Hassanein | President & CEO | Jul 14, 2026 |
| Edwin Kania | Director | May 22, 2026 |
| Stephanie Lovell | Director | May 22, 2026 |
| Merilee Raines | Director | May 22, 2026 |
| James R Tobin | Director | Aug 17, 2026 |
| David Weill | Director | Sep 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Fernando N. Araujo | See Remarks | Sep 29, 2026 |
| Giovanni Cecere | Chief Commercial Officer | Feb 20, 2026 |
| Nicholas Corcoran | See remarks | Jul 14, 2026 |
| Matthew S. Forsyth | See Remarks | May 21, 2026 |
| Waleed H Hassanein | President & CEO | Jul 14, 2026 |
| Gerardo Hernandez | Chief Financial Officer | Jul 14, 2026 |
| Anil P. Ranganath | See remarks | Mar 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | David Weill | Buy | 1,336 | $81.63 |
| Sep 11, 2026 | David Weill | Buy | 1,336 | $81.63 |
| Sep 11, 2026 | David Weill | Buy | 1,336 | $81.63 |
| Sep 11, 2026 | David Weill | Buy | 1,336 | $81.63 |
| Jun 15, 2026 | Thomas J. Gunderson | Sale | 9,624 | $75.06 |
| Jun 15, 2026 | Thomas J. Gunderson | Sale | 9,624 | $75.06 |
| Jun 15, 2026 | Thomas J. Gunderson | Sale | 9,624 | $75.06 |
| Jun 15, 2026 | Thomas J. Gunderson | Sale | 9,624 | $75.06 |
| Mar 4, 2026 | David Weill | Sale | 3,571 | $146.82 |
| Mar 4, 2026 | David Weill | Sale | 3,571 | $146.82 |
| Mar 4, 2026 | David Weill | Sale | 3,571 | $146.82 |
| Mar 4, 2026 | David Weill | Sale | 3,571 | $146.82 |
| Mar 4, 2026 | Stephanie Lovell | Sale | 1,193 | $149.62 |
| Mar 4, 2026 | Stephanie Lovell | Sale | 1,193 | $149.62 |
| Mar 4, 2026 | Stephanie Lovell | Sale | 1,193 | $149.62 |
TMDX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $190.29M | 4.87 | $192.84M |
| Dec 31, 2024 | — | $35.46M | 1.01 | $48.80M |
| Dec 31, 2023 | — | $-25.03M | -0.77 | $-13.03M |
| Dec 31, 2022 | — | $-36.23M | -1.23 | $-45.82M |
| Dec 31, 2021 | $31.39M | $-44.22M | -1.60 | $-28.86M |
Latest balance sheet: total assets $1.46B, total liabilities $946.34M, cash $330.09M (as of Jun 30, 2026).
TMDX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $80.75 |
| May 5, 2026 | 8-K Item 2.02 (results) | $94.93 |
| Feb 27, 2026 | 8-K Item 2.02 (results) | $145.26 |
| Feb 24, 2026 | 8-K Item 2.02 (results) | $137.78 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $134.32 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $107.70 |
| May 8, 2025 | 8-K Item 2.02 (results) | $93.20 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $72.12 |
| Oct 28, 2024 | 8-K Item 2.02 (results) | $126.24 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| Apr 30, 2024 | 8-K Item 2.02 (results) | — |
| Feb 26, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)Hyperfine (HYPR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TMDX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.